Cardiac biomarkers: Myths, facts and future horizons

Expert Review of Molecular Diagnostics

Volumn 7, Issue 6, 2007, Pages 693-697

  Dotsenko, Olena ^a   Chackathayil, Julia ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE; GLUCOSE; TROPONIN;

CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE PREDISPOSITION; EDITORIAL; HUMAN; INDUSTRIALIZATION; INFECTION; MICROALBUMINURIA; PATIENT ASSESSMENT; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEOMICS; RISK FACTOR; TREATMENT PLANNING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FORECASTING; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROTEOMICS; RISK FACTORS;

EID: 36448961270     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.6.693     Document Type: Editorial

References (33)

1. Wang TJ. Detecting circulating biomarkers of cardiovascular disease. Expert Rev. Mol. Diagn. 7(6), 793-804 (2007).
2. MacFadyen RJ. Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients. J. Hum. Hypertens. 20(6), 383-386 (2006). •• Discussion of the intraindividual variance of biomarkers.
3. Conen D, Pfisterer M, Martina B. Substantial intraindividual variability of BNP concentrations in patients with hypertension. J. Hum. Hypertens. 20(6), 387-391 (2006).
4. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511 (2003).
5. Ridker PM, Buring JE, Shih J et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98, 731-733 (1998).
6. Rossi E, Biasucci LM, Citterio F et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 105, 800-803 (2002).
7. Lip GY, Patel JV, Hughes E et al. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38, 1229-1237 (2007). • C-reactive protein in atrial fibrillation, demonstrating prognostic value for mortality.
8. Haverkate F, Thompson SG, Pyke SD et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349, 462-426 (1997).
9. Bogaty P, Brophy JM, Boyer L et al. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch. Intern. Med. 165, 221-226 (2005).
10. Folsom AR, Chambless LE, Ballantyne CM et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 166, 1368-1373 (2006).
11. van der Meer IM, de Maat MP, Kiliaan AJ et al. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch. Intern. Med. 163, 1323-1328 (2003).
12. Wang TJ, Gona P, Larson MG et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med. 355, 2631-2639 (2006).
13. Ridker PM, Buring JE, Rifai N et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 14, 611-669 (2007).
14. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347, 161-167 (2002). • Use of B-type natriuretic peptides for diagnosis of heart failure in the emergency room setting.
15. Berger R, Huelsman M, Strecker K et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105, 2392-2397 (2002).
16. Johnson AG, Pearce GL, Danoff TM. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. J. Hum. Hypertens. 20(7), 496-503 (2006).
17. Goetze JP, Christoffersen C, Perko M et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 17, 1105-1107 (2003).
18. Bassan R, Potsch A, Maisel A et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur. Heart J. 26, 234-240 (2005).
19. Kistorp C, Raymond I, Pedersen F et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293, 1609-1616 (2005).
20. Olsen MH, Hansen TW, Christensen MK et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur. Heart J. 28, 1374-1381 (2007).
21. Abdulle AM, Nagelkerke NJ, Adem A. Plasma N-terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population. J. Hum. Hypertens. 21(8), 647-653 (2007).
22. Bakris GL, Ruilope L, Locatelli F et al. Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial. J. Hum. Hypertens. 20(9), 693-700 (2006)
23. Luque M, de Rivas B, Alvarez B et al. Influence of target organ lesion detection (assessment of microalbuminuria and echocardiogram) in cardiovascular risk stratification and treatment of untreated hypertensive patients. J. Hum. Hypertens. 20(3), 187-192 (2006).
24. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler. Thromb. Vasc. Biol. 19, 617-624 (1999).
25. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112, 969-975 (2005).
26. Klausen K, Borch-Joknsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110, 32-35 (2004).
27. Klausen K, Scharling H, Jensen G. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J. Intern. Med. 260, 231-237 (2006).
28. Nelsestuen GL, Zhang Y, Martinez MB et al. Plasma protein profiling: unique and stable features of individuals. Proteomics 5, 4012-4024 (2005).
29. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577 (2002). •• Seminal paper on proteomics in cancer.
30. States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 24, 333-338 (2006).
31. Wong LY, Leung RY, Ong KL et al. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene - 572C>G polymorphism in subjects with and without hypertension. J. Hum. Hypertens. 21(11), 875-882 (2007).
32. Tekes S, Cikim AS. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension. J. Hum. Hypertens. 21(7), 546-550 (2007).
33. Nakhai-Pour HR, Grobbee DE, Bots ML et al. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. J. Hum. Hypertens. (2007) (Epub ahead of print).